{{Infobox medical condition (new)
| name            = 骨关节炎
| image           = Heberden-Arthrose.JPG
| caption         = The formation of hard knobs at the {{tsl|en|proximal interphalangeal joint||middle finger joints}} (known as {{tsl|en|Bouchard's nodes||Bouchard's nodes}}) and at the farther away finger joint (known as {{tsl|en|Heberden's node||Heberden's node}}) are a common feature of osteoarthritis in the hands.
| field           = [[风湿病学|风湿病学]]、[[矫形外科|矫形外科]]
| synonyms        = 退化性關節炎
| symptoms        = [[关节痛|关节痛]]、僵硬、{{tsl|en|joint effusion|關節積液}}，{{tsl|en|range of motion|關節活動度}}減低<ref name=NIH2015/>
| complications   = 
| onset           = 數年<ref name=NIH2015/>
| duration        = 
| causes          = 關節舊傷、關節及肢體發育異常、[[遺傳|遺傳]]因素<ref name=NIH2015/><ref name=Lancet2015/>
| risks           = [[超重|體重過重]]，長短腿、從事會增加關節負荷的職業<ref name=NIH2015/><ref name=Lancet2015/>
| diagnosis       = 根據症狀<ref name=NIH2015/>
| differential    = 
| prevention      = 
| treatment       = 運動、減低關節負荷、{{tsl|en|support group|支持團體}}、[[镇痛药|镇痛药]]、[[關節置換術|關節置換術]]<ref name=NIH2015/><ref name=Lancet2015/><ref name=OARSI2014/>
| medication      = 
| prognosis       = 
| frequency       = 2.37億人 / 3.3% （2015年）<ref name=GBD2015Pre>{{cite journal|last1=GBD 2015 Disease and Injury Incidence and Prevalence|first1=Collaborators.|title=Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.|journal=Lancet|date=8 October 2016|volume=388|issue=10053|pages=1545–1602|pmid=27733282|doi=10.1016/S0140-6736(16)31678-6|pmc=5055577}}</ref>
| deaths          = 
}}

<!-- Definition and symptoms -->
'''骨關節炎'''（Osteoarthritis，[[縮寫|縮寫]]：OA），或稱'''退化性關節炎'''，是一種{{tsl|en|articular cartilage|關節軟骨}}或關節下[[骨頭|骨頭]]損傷的[[關節炎|關節炎]]<ref>{{cite book|title=Atlas of Osteoarthritis|date=2015|publisher=Springer|isbn=9781910315163|page=21|url=https://books.google.com/books?id=qT1FBgAAQBAJ&pg=PA21|deadurl=no|archiveurl=https://web.archive.org/web/20170908174334/https://books.google.com/books?id=qT1FBgAAQBAJ&pg=PA21|archivedate=2017-09-08|df=}}</ref>，常見症狀是[[關節疼痛|關節疼痛]]或僵硬<ref name=NIH2015/>，初次發病常僅見於運動之後但發病次數會隨時間增加<ref name=NIH2015/>；其他症狀包含{{tsl|en|joint effusion|關節腫脹}}、{{tsl|en|range of motion|關節活動度}}降低，若進犯背部，則可能導致四肢無力或麻木<ref name=NIH2015/>。好發患病部位為手指末梢關節、拇指根部、頸部、下背部、膝蓋及臀部<ref name=NIH2015/>。骨關節炎常好發於特定一側，另一側則較少發生<ref name=NIH2015/>；常常會延續多年 <ref name=NIH2015/>，可能會影響到日常生活或工作<ref name=NIH2015/>，骨關節炎與其他關節炎不同，僅會侵犯關節，而不會進犯其他組織。<ref name=NIH2015/>

<!-- Cause and diagnosis -->
病因包含先前關節有受傷過、關節發育異常、[[遺傳|遺傳]]等因素<ref name=NIH2015/><ref name=Lancet2015/>，風險相對較高的族群包含[[體重過重|體重過重]]、長短腿、因工作而使關節長期承受高度壓力者等<ref name=NIH2015/><ref name=Lancet2015/>。一般認為機械性壓力或低度發炎乃造成骨關節炎的元凶<ref name=Berenbaum2013>{{cite journal |author=Berenbaum F |title=Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!) |journal=Osteoarthritis and Cartilage |volume=21 |issue=1 |year=2013 |pages=16–21 |doi=10.1016/j.joca.2012.11.012|pmid=23194896}}</ref>，患者的關節軟骨流失，進而磨損關節下的硬骨<ref name=NIH2015/>；骨關節炎會使運動時疼痛讓關節難以運作，可能導致[[萎縮|肌肉流失]]<ref name=Lancet2015>{{cite journal|last1=Glyn-Jones|first1=S|last2=Palmer|first2=AJ|last3=Agricola|first3=R|last4=Price|first4=AJ|last5=Vincent|first5=TL|last6=Weinans|first6=H|last7=Carr|first7=AJ|title=Osteoarthritis.|journal=Lancet|date=3 March 2015|pmid=25748615|doi=10.1016/S0140-6736(14)60802-3|volume=386|pages=376–87}}</ref><ref name=NICE>{{cite web |author=Conaghan P |title=Osteoarthritis — Care and management in adults |url=http://www.nice.org.uk/guidance/cg177/evidence/full-guideline-191761309 |format=PDF |date=2014 |deadurl=yes |archiveurl=https://web.archive.org/web/20151222152555/http://www.nice.org.uk/guidance/cg177/evidence/full-guideline-191761309 |archivedate=2015-12-22 |df= |access-date=2017-10-18 }}</ref>。確診通常是依病徵、症狀、[[醫學影像|醫學影像]]判定，偶爾會需其他檢測來確定是否有其他問題或釐清其他症狀<ref name=NIH2015/>；骨關節炎不像[[類風濕性關節炎|類風濕性關節炎]]，前者的關節通常既不會發熱也不會發紅，而後者主要是一種{{tsl|en|inflammatory arthritis|發炎性關節炎|發炎狀況}}<ref name=NIH2015/>。

<!-- Treatment and prognosis -->
治療方法包含運動、減輕關節負擔、參與相關{{tsl|en|support group|支持團體}}，使用[[止痛藥|止痛藥]]等<ref name=NIH2015/><ref name=OARSI2014>{{cite journal |vauthors=McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, Hawker GA, Henrotin Y, Hunter DJ, Kawaguchi H, Kwoh K, Lohmander S, Rannou F, Roos EM, Underwood M |title=OARSI guidelines for the non-surgical management of knee osteoarthritis |journal=Osteoarthr. Cartil. |volume=22 |issue=3 |pages=363–88 |year=2014 |pmid=24462672 |doi=10.1016/j.joca.2014.01.003 |url=}}</ref>，減輕關節負擔的方式包含多休息、使用[[拐杖|拐杖]]以及[[護具|護具]]<ref name=NIH2015/>，過重患者可能可以透過減重改善<ref name=NIH2015/>，有疼痛症狀可服用可優先使用[[普拿疼|普拿疼]] <ref name=NIH2015/>，若無效則可使用[[萘普生|萘普生]]及[[布洛芬|布洛芬]]等[[非類固醇消炎藥|非類固醇消炎藥]]（NSAIDs）<ref name=NIH2015>{{cite web|title=Osteoarthritis|url=http://www.niams.nih.gov/health_info/Osteoarthritis/default.asp|website=National Institute of Arthritis and Musculoskeletal and Skin Diseases|accessdate=13 May 2015|date=April 2015|deadurl=yes|archiveurl=https://web.archive.org/web/20150518090102/http://www.niams.nih.gov/health_info/Osteoarthritis/default.asp|archivedate=2015-05-18|df=}}</ref>；[[鴉片類藥物|鴉片類藥物]]則具有[[成瘾|成癮性]]，通常僅在短期療程中使用<ref name=NIH2015/><ref name="OARSI2014"/>。如果上述治療都無法緩解疼痛對日常生活的影響，接受{{tsl|en|joint replacement|人工關節置換術}}或許會有幫助<ref name=Lancet2015/>。人工關節一般可使用10至15年<ref>{{cite journal|last1=Di Puccio|first1=F|last2=Mattei|first2=L|title=Biotribology of artificial hip joints.|journal=World journal of orthopedics|date=18 January 2015|volume=6|issue=1|pages=77–94|pmid=25621213|doi=10.5312/wjo.v6.i1.77|pmc=4303792}}</ref>。

<!-- Epidemiology -->
在患有膝蓋或臀部關節炎的患者中，骨關節炎最為常見，約佔總人口的3.3%，影響約2.37億人<ref name=GBD2015Pre/><ref name=Mar2014>{{cite journal |vauthors = March L, Smith EU, Hoy DG, Cross MJ, Sanchez-Riera L, Blyth F, Buchbinder R, Vos T, Woolf AD |title=Burden of disability due to musculoskeletal (MSK) disorders |journal=Best Pract Res Clin Rheumatol |volume=28 |issue=3 |pages=353–66 |year=2014 |pmid=25481420 |doi=10.1016/j.berh.2014.08.002}}</ref>，在超過60歲的男性患者中佔10%，超過60歲的女性患者中佔18%<ref name=Lancet2015/>。骨關節炎也佔[[失能調整生命年|失能調整生命年]]的2%<ref name=Mar2014/>。澳洲約有190萬名患者<ref>{{cite journal|last=Elsternwick|title=A problem worth solving.|journal=Arthritis and Osteoporosis Victoria|year=2013|url=http://www.arthritisvic.org.au/Research/AOV-Funded-Research/Completed/A-Problem-Worth-Solving/APWS.aspx|deadurl=yes|archiveurl=https://web.archive.org/web/20150428084636/http://www.arthritisvic.org.au/Research/AOV-Funded-Research/Completed/A-Problem-Worth-Solving/APWS.aspx|archivedate=2015-04-28|df=}}</ref>，而美國則擁有約3000萬至5250萬名患者<ref name=cdc2016>{{cite web|url=https://www.cdc.gov/arthritis/data_statistics/arthritis-related-stats.htm|title=Arthritis-Related Statistics: Prevalence of Arthritis in the United States|publisher=Centers for Disease Control and Prevention, US Department of Health and Human Services|date=9 November 2016|deadurl=no|archiveurl=https://web.archive.org/web/20161229100602/https://www.cdc.gov/arthritis/data_statistics/arthritis-related-stats.htm|archivedate=29 December 2016|df=}}</ref><ref name=Cisternas2015>{{cite journal |title=Alternative Methods for Defining Osteoarthritis and the Impact on Estimating Prevalence in a US Population-Based Survey |vauthors = Cisternas MG, Murphy L, Sacks JJ, Solomon DH, Pasta DJ, Helmick CG |journal=Arthritis Care Res (Hoboken) |date=May 2016 |volume=68 |issue=5 |pages=574–80 |doi=10.1002/acr.22721}}</ref>而兩性患病比率皆會隨年齡層升高而愈見普遍<ref name=NIH2015/>。
[[File:Osteoarthritis.webm|thumb]]
{{TOC limit|3}}

==病因==
由於[[滑液關節|滑液關節]]的[[滑液|滑液]]（關節液）減少，導致原本應該充當骨關節中作為軟垫的軟骨不正常磨擦，造成破壞與退化。当軟骨退化後，便無法保护骨頭表面，在行走或站立時，身體重量使到退化的關節更加疼痛，因此減少運動，[[肌肉|肌肉]]跟隨萎縮，并且[[韌帶|韌帶]]也可能变得鬆弛。以下原因可導致骨關節炎：

原發性骨關節炎：
#[[年齡|年齡]]<ref name="multiple">{{Cite book | author =Russell J. Greene, Norman D. | title =Harris Pathology  and Therapeutics for Pharmacists | url =https://archive.org/details/pathologytherape00gree | location = UK |chapter=Rheumatology : musculoskeletal and connective tissue disease| publisher = Pharmaceutical Press | date = 2008 | pages = [https://archive.org/details/pathologytherape00gree/page/n770 744]-815 | ISBN = 978-0853696902 | accessdate = 2017-05-29  | language = en }}</ref>：>70%出現在75歲年老者，85%發生在75~79歲<ref name="doi10.1002/acr.21898">{{cite journal |author=Losina E., ''et al.'' |title=Lifetime risk and age at diagnosis of symptomaticc knee osteoarthritis in the US |journal=Arthritis Care Res(Hoboken) |volume=65 |issue=5 |pages=703-711|doi=|url=https://dx.doi.org/10.1002%2Facr.21898|date=November 2013}}</ref>
#撕裂<ref name="multiple" />
繼發性骨關節炎： 
#外傷<ref name="multiple" /><ref name="doi10.1002/acr.21898"/>： 運動傷害<ref name="multiple" />、[[骨折|骨折]]<ref name="multiple" />、[[脫臼|脫臼]]<ref name="multiple" />、關節手術<ref name="multiple" />
#[[肥胖|肥胖]]<ref name="multiple" /><ref name="doi10.1002/acr.21898" /><ref name="PAA" />
#免疫缺乏病人<ref name="multiple" />： 如[[艾滋病|AIDS]]<ref name="multiple" />、hypogammaglobulinemia<ref name="multiple" />
#[[基因|基因]]<ref name="multiple" /><ref name="PAA">{{Cite book | author =Lucinda M. Buys and Mary Elizabeth Elloitt | title =Pharmacotherapy A Pathophysiologic Approach| location = US |chapter=Osteoarthritis| publisher = McGraw-Hill Medical | date = 2014 | pages = 9265-9406 | ISBN =978-0071800532 | accessdate = 2017-05-29  | language = en }}</ref>：Col11A1<ref name="multiple" />（[[細胞外基質|細胞外基質]]）、COL2A1<ref name="RPCF4">{{Cite book | author =Roberto A. Garcia,Michael J.Klein,Alan L.Schiller| title =Rubin’s Pathology Clinicopathologic Foundations of Medicine| location = USA |chapter=Bones and Joints| publisher = Lippincott Williams & Wilkins| date = 2011 | pages = 1199-1272| ISBN =978-1605479682| accessdate = 2017-05-29  | language = en }}</ref>（第二型[[膠原蛋白|膠原蛋白]]）、Chrom 19<ref name="multiple" />（[[軟骨|軟骨]]型態）、 MCFL<ref name="multiple" />（疼痛知覺）、 CHST11<ref name="multiple" />（[[軟骨|軟骨]]型態）、 GDF5<ref name="multiple" />（TCF-alpha訊息）  、 Chrom7Q22<ref name="multiple" />基因
#[[發炎|發炎]]<ref name="multiple" />：[[類風濕關節炎|類風濕關節炎]]<ref name="multiple" />、[[痛風|痛風]]<ref name="multiple" />、pseudogout<ref name="multiple" />、septic arthritis<ref name="multiple" />
#骨頭疾病<ref name="multiple" />：Paget's disease<ref name="multiple" />
#[[藥物|藥物]]<ref name="multiple" />： [[皮質類固醇|皮質類固醇]][[藥物|藥物]]治療導致[[骨頭|骨頭]][[壞死|壞死]]<ref name="multiple" />、[[注射|注射]]不溶物進入[[關節|關節]]<ref name="multiple" />

==病理機轉==
滑膜性[[關節|關節]]（synovial joints）裡的一項組成：[[軟骨細胞|軟骨細胞]]，合成[[基質|基質]]以及[[消化|消化]]老化[[細胞|細胞]]或物質，亦會[[分泌|分泌]]非[[活化|活化]]降解酶於[[基質|基質]]中與[[酵素抑制劑|酵素抑制劑]]<ref name=Robbins5>{{Cite book | author =Horvai Andrew | title =Robbins and  Cotran Pathologic Basis of Disease, Professional Edition | location = USA |chapter=Bones,Joints,and Soft Tissue  Tumors| publisher = Saunders| date = 2014 | pages = 1179-1226 | ISBN = 978-0323266161 | accessdate = 2017-05-29  | language = en }}</ref>，使[[關節|關節]]中[[基質|基質]]的[[合成|合成]]和[[代謝|代謝]]呈現[[動態平衡|動態平衡]]<ref name=Harrison6>{{Cite book | author =David T. Felson | title =Harrison’s Principles of Internal Medicine| location = USA |chapter=Osteoarthritis| publisher = McGraw-Hill | date = 2015 | pages = 2226-2233| ISBN =  978-0071802154 | accessdate = 2017-05-29  | language = en }}</ref>。當異化酶（catabolic enzyme）被活化，[[抑制劑|抑制劑]]產生減少，[[基質|基質]]被[[分解|分解]]的速度便加快<ref name="Harrison6" />。[[細胞激素|細胞激素]]（像是IL-1和TNF）也會啟動降解路徑<ref name="Robbins5" />。

當某些目前尚未清楚的[[生化|生化]]因素、機械因素誘導[[軟骨細胞|軟骨細胞]]改變<ref name="PAA" />其[[基因|基因]]表現而大量製造[[發炎|發炎]][[細胞激素|細胞激素]]<ref name="Harrison6" />和matrix metalloproteinases<ref name="multiple" /><ref name="Harrison6" />（MMP）（尤其是ADAMTS-5 和 膠原蛋白酶<ref name="Harrison6" />）— 分解[[軟骨|軟骨]][[基質|基質]]中相當關鍵的[[酵素|酵素]]。

而後，滑膜中的[[巨噬細胞|巨噬細胞]]和MMP開始分解[[膠原蛋白|膠原蛋白]]、[[蛋白聚糖|蛋白聚糖]]，並釋放前[[發炎|發炎]][[細胞激素|細胞激素]]<ref name="Harrison6" />（像是TNFα , IL-1, IL-6），IL-1β與[[軟骨|軟骨]][[細胞|細胞]]表面上的[[受體|受體]]結合[6]，釋放MMP<ref name="multiple" />和抑制製造第二型[[膠原蛋白|膠原蛋白]]<ref name="multiple" />，因此加速分解[[軟骨|軟骨]]<ref name="Harrison6" />；TNFα 誘導[[軟骨細胞|軟骨細胞]]合成PGE2和NO<ref name="Harrison6" />。在這過程中，位於[[軟骨|軟骨]]深層的[[軟骨細胞|軟骨細胞]]會開始[[增生|增生]]和大量製造[[基質|基質]]，以維持[[恆定|恆定]]，但最終仍無法超越分解的速度<ref name="Robbins5" /><ref name="Harrison6" />。這樣的過程導致[[關節|關節]]中[[細胞外基質|細胞外基質]]的[[水部_(部首)|水]]含量上升，[[蛋白聚糖|蛋白聚糖]]含量下降，[[軟骨|軟骨]]也因為漸漸被分解而弱化，也因為[[血管生成抑制素|血管生成抑制素]]合成降低和VEGF合成，使得[[血管|血管]]伸入[[關節|關節]]內，此外，[[軟骨細胞|軟骨細胞]]開始[[凋亡|凋亡]]<ref name="Robbins5" /><ref name="Harrison6" />。

[[軟骨|軟骨]]的減少帶動軟骨下骨開始變動，在[[生長因子|生長因子]]和[[細胞激素|細胞激素]]的刺激下，成骨細胞和破骨細胞被活化，導致新生[[骨頭|骨頭]]，增厚和僵硬軟骨下板、[[軟骨|軟骨]][[骨化|骨化]]<ref name="Harrison6" />。

== 分类 ==
# '''原发性''' 指发病原因不明，患者没有[[创伤|创伤]]、[[感染|感染]]、[[先天性畸形|先天性畸形]]病史，无[[遗传性缺陷|遗传性缺陷]]，无全身代谢及内分泌异常。多见于50岁以上的中老年人。
# '''继发性''' 指由于先天性畸形，如[[先天性髋关节脱位|先天性髋关节脱位]]；创伤，如[[关节内骨折|关节内骨折]]；关节面后天性不平整，如骨的缺血性坏死；关节不稳定，如[[关节囊|关节囊]]或[[韧带|韧带]]松弛等；关节畸形引起的关节面对合不良，如[[膝内翻|膝内翻]]、[[膝外翻|膝外翻]]等原因，在关节局部原有病变的基础上发生的骨关节炎。

==症狀==
[[疼痛|疼痛]]<ref name="multiple" /><ref name="RPCF4" /><ref name="Robbins5" /><ref name="Harrison6" /><ref name=Pa9>{{Cite book | author =黃玄贏、林瑞偉| title =病 理學| location = 新北市 |chapter=骨骼、關節及肌肉疾病| publisher = 新文京| date = 2012 | pages = 523-556 | ISBN = 9789862366905 | accessdate = 2017-05-29  | language = zh }}</ref>（且疼痛會隨關節的使用而加劇<ref name="multiple" /><ref name="RPCF4" /><ref name="Harrison6" /><ref name="Pa9" />）、晨間僵硬<ref name="multiple" /><ref name="RPCF4" /><ref name="Robbins5" /><ref name="Harrison6" />、有[[骨骼|骨骼]]相互摩擦的[[關節|關節]]或是嘎吱作響<ref name="multiple" /><ref name="RPCF4" /><ref name=WO8>{{cite journal |author=Waiwah Chung|title=What is Osteroarthritis|journal=National  Institute of Arthritis and Musculoskeletal and Skin Diseases  Information Clearinghouse|date=November 2014}}</ref>、[[關節|關節]]活動受限<ref name="multiple" /><ref name="RPCF4" /><ref name="Pa9" />、[[關節|關節]]膨大（Heberden’s and Bouchard’s nodes）<ref name="multiple" /><ref name="RPCF4" />、[[半月板|半月板]]撕裂<ref name="Harrison6" />

== 治療 ==
;物理治療<ref name="multiple" />：

適當的運動<ref name="PAA" />（例如[[游泳|游泳]]<ref name="Harrison6" />），維持並恢復肌力，尤其在[[手術|手術]]後。使用[[裝具|裝具]]<ref name="Harrison6" />

;居家治療<ref name="multiple" />：

於家中加裝無障礙設施。

; 药物<ref name="multiple" /><ref name=understand>{{Cite book | author =Sue E. Huether, Kathryn L.| title =Understanding Pathophysiology| url =https://archive.org/details/pathophysiologyo0000huet| location = USA |chapter=Alterations of Musculoskeletal  Function| publisher = Mosby | date = 2016 | pages = 3031-3060 | ISBN = 978-0323354097 | accessdate = 2017-05-29  | language = en }}</ref>：
*口服[[非類固醇消炎止痛藥|非類固醇消炎止痛藥]]（NSAID）和[[環氧合酶|環氧合酶]]COX-2[[抑制劑|抑制劑]]：
**[[萘普生|萘普生]]<ref name="PAA" /><ref name="Harrison6" />：毒性低，可給老年者服用<ref name="PAA" />
**{{Le|Salsalate|}}<ref name="Harrison6" />
**[[布洛芬|布洛芬]]<ref name="Harrison6" />
**[[美洛昔康|美洛昔康]]<ref name="PAA" />
**{{Le|Aceclofenac|}}<ref name="PAA" />：宣稱可以促進[[關節|關節]]修復<ref name="PAA" />
*局部服用[[非類固醇消炎止痛藥|非類固醇消炎止痛藥]]（NSAID）：臨床研究結果顯示，外用NSAID的效果稍差但各種副作用少得多，不過仍有刺激皮膚的可能。
**[[双氯芬酸|双氯芬酸]]<ref name="Harrison6" />: 第一線用藥<ref name="PAA" />
*鴉片類藥物：
**[[可待因|可待因]]<ref name="PAA" />：第二線用藥<ref name="PAA" />
**{{Le|Dihydrocodeine|}}<ref name="PAA" />：第二線用藥<ref name="PAA" />
**[[曲馬多|曲馬多]]<ref name="PAA" />：第一線用藥<ref name="PAA" />
*[[關節|關節]]內[[注射|注射]]
**[[類固醇|類固醇]]<ref name="Harrison6" />：滑液囊[[發炎|發炎]]是骨關節炎[[疼痛|疼痛]]的主因，故局部注射抗發炎藥物可以有效的止痛。但在臨床試驗中，[[類固醇|類固醇]]的止痛效果雖然不錯但效果持續時間只比安慰劑組多2週左右，因此頂多用在短期止痛。
**[[透明质酸|玻尿酸]]：與[[安慰劑|安慰劑]]相比，玻尿酸注射對膝關節炎沒有幫助<ref name="Rutjes12">{{cite journal | vauthors = Rutjes AW, Jüni P, da Costa BR, Trelle S, Nüesch E, Reichenbach S | title = Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis | journal = Annals of Internal Medicine | volume = 157 | issue = 3 | pages = 180–91 | date = August 2012 | pmid = 22868835 | doi = 10.7326/0003-4819-157-3-201208070-00473 | url = https://semanticscholar.org/paper/77dbe5ccae50fed08e452ed4e940fa78c05d88e6 }}</ref><ref>{{cite journal | vauthors = Jevsevar D, Donnelly P, Brown GA, Cummins DS | title = Viscosupplementation for Osteoarthritis of the Knee: A Systematic Review of the Evidence | journal = The Journal of Bone and Joint Surgery. American Volume | volume = 97 | issue = 24 | pages = 2047–60 | date = December 2015 | pmid = 26677239 | doi = 10.2106/jbjs.n.00743 }}</ref>，但增加後續疼痛風險<ref name="Rutjes12">{{cite journal | vauthors = Rutjes AW, Jüni P, da Costa BR, Trelle S, Nüesch E, Reichenbach S | title = Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis | journal = Annals of Internal Medicine | volume = 157 | issue = 3 | pages = 180–91 | date = August 2012 | pmid = 22868835 | doi = 10.7326/0003-4819-157-3-201208070-00473 | url = https://semanticscholar.org/paper/77dbe5ccae50fed08e452ed4e940fa78c05d88e6 }}</ref>。踝關節炎方面，證據尚不清楚<ref>{{cite journal | vauthors = Witteveen AG, Hofstad CJ, Kerkhoffs GM | title = Hyaluronic acid and other conservative treatment options for osteoarthritis of the ankle | journal = The Cochrane Database of Systematic Reviews | volume = 10 | issue = 10 | pages = CD010643 | date = October 2015 | pmid = 26475434 | doi = 10.1002/14651858.CD010643.pub2 | quote = It is unclear if there is a benefit or harm for HA as treatment for ankle OA }}</ref>。
**[[皮質類固醇|皮質類固醇]]：第一線用藥<ref name="PAA" />，只能短暫使用，長期使用具危險性<ref name="PAA" />
*混合使用：
**[[对乙酰氨基酚|对乙酰氨基酚]]加上可待因或Dihydrocodeine<ref name="PAA" />
*[[抗憂鬱藥|抗憂鬱藥]]物：
**[[度洛西汀|度洛西汀]]<ref name="PAA" />：第二線用藥<ref name="PAA" />、紓解長期[[疼痛|疼痛]]的[[憂鬱|憂鬱]]<ref name="PAA" />
*[[賀爾蒙|賀爾蒙]][[替代療法|替代療法]]<ref name="PAA" />：有[[致癌|致癌]]風險<ref name="PAA" />
*其他藥物：
**[[辣椒素|辣椒素]]<ref name="PAA" />：第一線用藥<ref name="PAA" />、降低物質P，但會刺激粘膜<ref name="PAA" />
**[[乙醯氨酚|乙醯氨酚]]<ref name="PAA" /><ref name="Harrison6" />：是處理疼痛的第一線用藥<ref name="PAA" />，只有止痛效果而無抗發炎作用，但副作用較輕微。

;[[手術|手術]]：嚴重，無法控制的疼痛與嚴重功能損失時用<ref name="multiple" />
*{{Le|關節置換術|Arthroplasty}}<ref name="multiple" /><ref name="Robbins5" /><ref name="WO8" />
*[[关节镜|关节镜]]清創<ref name="multiple" /><ref name="Harrison6" />
*{{Le|Arthrodesis|}}<ref name="multiple" />：可以減輕[[疼痛|疼痛]]， 但關節活動會受限<ref name="PAA" />
*{{Le|切骨術|Osteotomy}}<ref name="PAA" />：移除[[壞死|壞死]][[组织_(生物学)|組織]]
*[[軟骨細胞|軟骨細胞]][[移植|移植]]<ref name="Harrison6" />

;控制體重<ref name="PAA" /><ref name="Harrison6" /><ref name="WO8" />

== 预防 ==
预防包括控制体重、运动时注意保护关节，劳逸结合，防止关节过度磨损。

== 参见 ==
*[[內側磨擦症候群|內側磨擦症候群]]（Medial Abrasion Syndrome, MAS）
*[[拇趾滑液囊炎|拇趾滑液囊炎]]（bunion）

== 参考文献  ==
=== 引用 ===
{{Reflist}}

=== 来源 ===
; 书籍
{{refbegin}}
* {{cite book
 |author = 吴在德
 |year=2008 |title = 外科学（第7版）
 |publisher = 人民卫生出版社 |ISBN = 9787117096218 }}
* {{cite book
 |last = Longo
 |first = Fauci
 |coauthors = et al<!-- Note: the single quote mark before the name is correct. -->
 |year=2012 |title=哈里遜內科學（第18版）第二冊
 |publisher = McGraw-Hill compabies, Inc |ISBN = 9780071748872 }}
* 张艳宏. 穴位贴敷疗法的理论基础及目前应用现状[J]. 甘肃中医, 2007, (2):1-3.
{{refend}}

== 外部連結 ==
{{commons category|Osteoarthritis}}
{{Portal box|医学}}
* [http://www.rheumatology.org/practice/clinical/patients/diseases_and_conditions/osteoarthritis.asp American College of Rheumatology Factsheet on OA]
* [http://www.arthritis.org/ Arthritis Foundation] {{Wayback|url=http://www.arthritis.org/ |date=20070423120449 }}
* [https://web.archive.org/web/20150116000259/http://niams.nih.gov/Health_Info/Arthritis/default.asp National Institute of Arthritis and Musculoskeletal and Skin Diseases]
*[http://www.chinatimes.com/realtimenews/20161231002584-260405 膝關節保健必知]

{{關節病變和相關疾病}}

{{Authority control}}

[[Category:關節炎|Category:關節炎]]